文献速递其他结缔组织病

系统性硬化症相关间质性肺病疾病严重程度、临床病程和结局判定的异质性:一项系统文献综述

Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.
PubMed 文献 · RMD Open · 2023-01-01

该系统文献综述依据PRISMA指南检索Medline、Embase、Web of Science和Cochrane Library至2023年8月1日,共筛选9054篇论文并最终纳入342篇,旨在汇总系统性硬化症相关间质性肺病(SSc-ILD)严重程度、进展和结局的现有证据。结果显示,最常用的进展和严重程度判定工具包括一氧化碳弥散量(DLCO)与用力肺活量(FVC)的联合变化、单独FVC或DLCO变化、高分辨率CT(HRCT)扩展范围以及包含肺功能检查、临床体征和HRCT数据的复合算法;死亡率是最常报告的长期事件。作者结论指出,现有定义呈现高度异质性,强调需要制定标准化的共识定义来界定严重SSc-ILD。

要点

  • 该系统文献综述最终纳入342篇论文,汇总SSc-ILD严重程度、进展和结局的判定定义。
  • 最常用的进展和严重程度判定工具包括DLCO与FVC联合变化、单独FVC或DLCO变化、HRCT扩展范围和复合算法。
  • 死亡率是最常报告的长期事件,包括全因死亡和ILD相关死亡。

核心结论

  • 作者结论指出,呈现SSc-ILD「进展」「严重程度」和「结局」定义的研究显示高度异质性。
  • 作者认为这些结果强调需要制定标准化的共识定义来界定严重SSc-ILD,以将疾病特异性进展定义作为临床试验和临床实践的替代结局。

研究设计与样本

  • 该系统文献综述按照PRISMA指南在Medline、Embase、Web of Science和Cochrane Library中检索至2023年8月1日,检索SSc-ILD严重程度、进展和结局的定义。
  • 共审查9054篇论文,最终纳入342篇。
  • PROSPERO注册号CRD42022379254。

主要发现

  • 用于定义SSc-ILD进展和严重程度的最常用工具包括DLCO与FVC的联合变化、单独FVC或DLCO变化、HRCT扩展范围以及包含肺功能检查、临床体征和HRCT数据的复合算法。
  • 死亡率是最常报告的长期事件,包括全因死亡和ILD相关死亡。
  • 作者指出,大多数提出的进展性肺纤维化或SSc-ILD严重程度定义基于IPF患者的研究数据,未在SSc-ILD患者中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective The course of systemic sclerosis-associated interstitial lung disease (SSc-ILD) is highly variable and different from continuously progressive idiopathic pulmonary fibrosis (IPF). Most proposed definitions of progressive pulmonary fibrosis or SSc-ILD severity are based on the research data from patients with IPF and are not validated for patients with SSc-ILD. Our study aimed to gather the current evidence for severity, progression and outcomes of SSc-ILD.Methods A systematic literature review to search for definitions of severity, progression and outcomes recorded for SSc-ILD was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in Medline, Embase, Web of Science and Cochrane Library up to 1 August 2023.Results A total of 9054 papers were reviewed and 342 were finally included. The most frequent tools used for the definition of SSc-ILD progression and severity were combined changes of carbon monoxide diffusing capacity (DLCO) and forced vital capacity (FVC), isolated FVC or DLCO changes, high-resolution CT (HRCT) extension and composite algorithms including pulmonary function test, clinical signs and HRCT data. Mortality was the most frequently reported long-term event, both from all causes or ILD related.Conclusions The studies presenting definitions of SSc-ILD 'progression', 'severity' and 'outcome' show a large heterogeneity. These results emphasise the need for developing a standardised, consensus definition of severe SSc-ILD, to link a disease specific definition of progression as a surrogate outcome for clinical trials and clinical practice.PROSPERO registration number CRD42022379254.Cite Now.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Petelytska L, Bonomi F, Cannistrà C, et al. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review. RMD Open. 2023. PMID: 37940340. doi:10.1136/rmdopen-2023-003426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。